Journal article
Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin‐3, and NT‐ProBNP Before Cardiac Surgery
Abstract
BACKGROUND: Current preoperative models use clinical risk factors alone in estimating risk of in-hospital mortality following cardiac surgery. However, novel biomarkers now exist to potentially improve preoperative prediction models. An assessment of Galectin-3, N-terminal pro b-type natriuretic peptide (NT-ProBNP), and soluble ST2 to improve the predictive ability of an existing prediction model of in-hospital mortality may improve our …
Authors
Polineni S; Parker DM; Alam SS; Thiessen‐Philbrook H; McArthur E; DiScipio AW; Malenka DJ; Parikh CR; Garg AX; Brown JR
Journal
Journal of the American Heart Association, Vol. 7, No. 14,
Publisher
Wolters Kluwer
Publication Date
July 17, 2018
DOI
10.1161/jaha.117.008371
ISSN
2047-9980